Maestro Healthcare Technology, Inc.

Maestro Healthcare Technology, Inc. focuses on technology-driven solutions for self-funded health plans, aiming to enhance healthcare efficiency and reduce costs through innovative products and services. Founded in 2013 and headquartered in Chicago, US, Maestro Healthcare Technology, Inc. is a third-party administrator specializing in self-funded health plans.

The company underwent a significant transition when it was acquired by AXA Group in February 2018 for USD 155 mn, integrating it into AXA's health business strategy. The company has completed a total of 4 deals since its inception, with the most recent deal occurring on January 22, 2018. CEO Craig Maloney and Rob Butler lead the organization, leveraging their expertise in healthcare technology to expand service offerings. Maestro Healthcare Technology, Inc.

offers Marpai, a technology-driven third-party administrator (TPA) specializing in self-funded health plans. Their services encompass health plan administration, access to top provider networks, SMART claims processing, and in-house clinical management. Marpai’s platform employs artificial intelligence and machine learning to enhance healthcare efficiency, primarily serving small employers with fewer than 100 employees across the United States, enabling them to access comprehensive healthcare benefits at reduced costs. Maestro Healthcare Technology, Inc.

generates revenue through fees for its TPA services, including health plan administration and clinical management. Their business-to-business model serves mainly small to mid-sized employers, with revenue streams derived from service fees, subscription agreements, and performance-based incentives linked to cost savings. Key offerings such as the Marpai Vitality Plan and Pharmacy Benefit Management (PBM) solution are tailored to meet client needs and improve healthcare outcomes while controlling costs. In January 2018, AXA Group acquired Maestro Healthcare Technology, Inc.

as part of its strategy to enhance its health business and support a long-term population health management solution. This acquisition will facilitate future growth by allowing Maestro to develop new products and expand its services into additional markets as AXA implements its Payer-to-Partner strategy. Specific details regarding new product launches or geographic expansions have not been disclosed, but the backing of AXA Group suggests a strong commitment to enhancing Maestro’s offerings in the healthcare technology sector.